Discovery aids disease elimination efforts
David Horn: Professor of Parasite Molecular Biology, University of Dundee
Researchers at the University of Dundee have identified a new drug target in parasites that cause major neglected tropical diseases, a discovery that contributes towards a...
Six Years of Exercise or Lack of It – May Be Enough to Change...
By analyzing reported physical activity levels over time in more than 11,000 American adults, Johns Hopkins Medicine researchers conclude that increasing physical activity to recommended levels over as few as six years in middle...
Improved radionuclide supply can transform nuclear medicine
Targeted Alpha Therapy (TAT) is a promising cancer treatment in nuclear medicine, but the supply of alpha-emitting radionuclides - which the treatment relies on - is very limited. A lack of alpha-emitting radionuclides in...
Wolfson Centre – Short Courses for 2024
The short course calendar for 2024 has been released and online registration is open.
Held either online or at the Wolfson Centre for Bulk Solids Handling Technology offices in Chatham, Kent, we offer courses in...
COVID-19 TESTING SECTOR DEMAND SET TO CONTINUE AMID VACCINE ROLLOUT
Amid the continued high demand for testing and staggered vaccine rollout, the diagnostics industry, which was valued in 2020 at $17.2bn-$19.8bn, is set to rise further in 2021
The diagnostics sector will continue to see...
Cell therapy manufacturing industry takes big steps forward
Cell Therapy production across the world has made some significant advances in recent months, with investment in manufacture announced and exciting research suggesting new applications.
The industry in the UK has taken a step forward...
A Tale of Two Crises
Unfortunately, it appears that being slow to recognise a crisis is part of the human condition, and medical research has had its fair share. Often there needs to be a key event (or series...
Using apprenticeships to build skills for innovation in life sciences
Dr. Gillian Burgess, Site Head of UK Research and Vice President at Vertex Pharmaceuticals and Board Member of the Science Industry Partnership (SIP) of employers, sets out the business case for greater use of apprenticeships across...
There’s more to collagen than cosmetics…
Big strides are being made in collagen clinical development, particularly in treatment of age-related conditions. Dr Gen Li, president and founder of Phesi, discusses the increase in collagen research, and its clinical and biological...
UK firm plans state-of-the-art precision medicine centre in California
Working with local partners, BIOS Health, of Cambridge, will create a cutting-edge research and clinical trials center for neural digital therapies. The centre will be built around BIOS’s real-time insights into the nervous system,...
Protecting the confidentiality of individuals vs. the desire to improve healthcare through data
Wendy Lloyd-Goodwin, Founder of Life Science Law, looks at the implications of a new EU-wide framework for health data, including for research and clinical trials.
The EU is hoping to achieve a quantum leap forward...
Access to Intellectual Property (IP) Rights in a Time of Emergency – Patent Pools...
Alex Bone, Patent Attorney, Partner, AA Thornton
The pharmaceutical and healthcare industry is often accused of misusing IP to extend exclusivity and delay reasonably priced access to life saving technologies. The recent pandemic has focussed attention...
EU-wide IP Expertise is essential to the life science industry post-Brexit
The UK is world-renowned for its progressive life science and healthcare sectors, which are at the forefront of technical innovation, research excellence, and pioneering treatments.
Life science companies, research and development facilities, scientists and academics...
Work begins on £62m expansion of NETPark
Work is underway on the exciting £62M expansion of one of the UK’s premier science parks.
Led by Business Durham and funded by Durham County Council, the development of Phase 3 of the North East...
Major steps being taken in battle against arthritis
Researchers from many disciplines are working together to ease the pain of rheumatoid arthritis patients and potentially save the NHS millions of pounds on ineffective drugs.
Doctors can waste a long time prescribing different therapies...
With Great promise comes great responsibility
In the world of drug production, the search is relentless for treatments that can reduce the planet’s spiralling pharmaceutical bill by curing illness.
However, although billions of pounds is ploughed into developing new drugs, attention...